Atlas Trials

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Clinical trial NCT00258232 · COMPLETED

Trial details

NCT number
NCT00258232
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2002-01-01
Primary completion
2007-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.